Our Team

Medical Affairs and Clinical Development Executive Leader
Dr. Larisa Yedigarova is a physician-researcher with over 35 years of global experience spanning clinical practice, academia, and the pharmaceutical industry. As a strategic leader in Medical Affairs and Clinical Development, she has played a pivotal role in five high-profile product launches at Novo Nordisk, Amgen, Allergan/AbbVie, Avanir/Otsuka, and Medtronic Diabetes.

With expertise across multiple therapeutic areas—including endocrinology, cardiovascular, cardiometabolic diseases, obesity, renal disorders, lipidology, neurology, and women’s health—Dr. Yedigarova has led cross-functional teams, developed innovative medical strategies, and managed multimillion-dollar budgets.

Her global clinical research leadership extends across the US, Canada, Europe, the Middle East, Australia, and Central Asia, fostering strong collaborations with Key Opinion Leaders (KOLs) and regulatory bodies. She has been instrumental in developing and leading innovative advisory boards as well as in shaping real-world evidence strategies, investigator-initiated studies, omnichannel KOL engagement, and HEOR initiatives, significantly advancing therapy access and patient outcomes.

Dr. Yedigarova is multilingual, fluent in English, Russian, Armenian, and proficient in Ukrainian, enabling seamless communication in diverse research and regulatory environments. She has authored over 80 peer-reviewed publications and contributed to groundbreaking clinical research, advisory board leadership, and regulatory submissions.

A dedicated educator, she serves as an Adjunct Professor at the University of Southern California (USC) Mann School of Pharmacy and Pharmaceutical Sciences, mentoring future leaders in pharmaceutical brand development and clinical research.

Dr. Yedigarova is a recognized leader in professional circles, actively engaging with the American Diabetes Association (ADA), American Heart Association, and American Stroke Association.

Her dedication to advancing medical science, global healthcare strategies, and innovative patient-centric solutions continues to make a profound impact on the field.

Executive Leader | Sales Strategy | MedTech Commercialization Expert

With over two decades of leadership experience in the healthcare industry, Jean helps companies drive growth and bring innovations to market through expert consulting in sales leadership, clinical go-to-market strategy, and customer engagement. She partners with organizations to uncover their “Ah-Ha” moments—those pivotal insights that accelerate adoption, expand market share, and deliver measurable business impact.

Jean is a subject matter expert in medical devices and diagnostic technologies, with deep experience across healthcare systems, payer dynamics, clinician training, and product launch strategies. Her approach is both strategic and execution-focused, grounded in a track record of leading high-performance teams, refining resonant messaging, and delivering strong commercial outcomes.

Over her 25+ year career, Jean has held commercial leadership roles at Medtronic, Boston Scientific, Zoll, and several MedTech startups. She has led value-based selling initiatives, built and scaled national and strategic account teams, and developed training programs that have empowered thousands of clinicians across the U.S.

Jean brings practical expertise in commercializing disruptive technologies, integrating CRM systems, engaging KOLs and patient ambassadors, and establishing partnerships with professional medical societies such as ACC and HFSA. Her accomplishments include launching the first implantable CGM sensor in the U.S., doubling national HCP training targets, and leading go-to-market planning forcardiovascular and metabolic health solutions.

She holds a Bachelor of Business Administration from the University of Cincinnati and has completed executive education in Management at Rollins College, Strategic Leadership at the Wharton School, and Digital Marketing at MIT.

Organizations seeking to elevate sales strategy, enhance market development, or commercialize innovative healthcare solutions turn to Jean for her vision, expertise, and proven impact.

Health Policy and Reimbursement Expert

Healthcare Hospital Executive

Sandra brings extensive knowledge of health policy, hospital operations, observation medicine, and reimbursement, which had allowed the healthcare industry to augment its products, services, and grow market share. She lead's a nationally known consulting company that specialized in healthcare operations and management. Having worked with over 2000 hospitals in the U.S.  Sandra built a reputation for developing fundamentally sound operations plans that deliver positive results. Nationally known as a Healthcare Reform Business Analyst.  She gained the attention of CMS and affiliated agencies by having her experience published in national and international publications and by advising and presenting to hospitals and well-known organizations such as the Centers of Medicare and Medicaid Services, National Quality Forum, National Institute of Health, American College of Cardiology, the American College of Healthcare Executives, and the American College of Emergency Medicine. 

Sandra Sieck has served as a board member as well as the Chief Operating Officer for the Society of Chest Pain Centers, international as well as the Chief Operating Officer (COO).  She was a selected committee member of the National Institute for Health (NIH) National Heart, Lung, Blood Institute (NHBLI) to address the nations HealthCare Initiative Cardiovascular Disease and Women (Healthy People Initiative 2010), and CMS-APC Observation Reimbursement Committee (one of the original team members who challenged CMS regarding the new observation code). Ms. Sieck served on the NQF panel for development of Pain Management Quality Measures.

 Ms. Sieck worked with CMS/NCHS in updating ICD-9 Codes to meet the Cardiology National Guidelines and Medical Necessity Standards.  Ms. Sieck worked with the Federal government in monitoring and updating Health policy.   In addition to developing unique healthcare concepts, Ms. Sieck has developed a one of its kind, nationally recognized program, “A New Generation of Hospital Operations - The industry leader in the alliance of clinical and financial data platform, the Y Model”.  She also has numerous publications.  She was interviewed by Forbes Magazine regarding the impact of Observation Services on the patient, financially.